Apexian Pharmaceuticals is a clinical stage biotechnology company founded on the scientific discoveries of Dr. Mark R. Kelley, whose work on the APE1/Ref-1 protein has provided unique insight into this important biological target. APE1/REF-1 plays a key role in a variety of inflammatory disorders and tumorigenesis, including cancers of the colon, pancreas, skin, blood, diabetic macular edema, inflammatory bowel disorders and o...
Apexian Pharmaceuticals is a clinical stage biotechnology company founded on the scientific discoveries of Dr. Mark R. Kelley, whose work on the APE1/Ref-1 protein has provided unique insight into this important biological target. APE1/REF-1 plays a key role in a variety of inflammatory disorders and tumorigenesis, including cancers of the colon, pancreas, skin, blood, diabetic macular edema, inflammatory bowel disorders and others.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.